[High dose rate prostate brachytherapy].

P Nickers, P Blanchard, J-M Hannoun-Lévi, A Bossi, O Chapet, S Guérif
Author Information
  1. P Nickers: Département universitaire de radiothérapie et curiethérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. p-nickers@o-lambret.fr

Abstract

This article aims at presenting the interest of high dose rate brachytherapy in the radiation treatment of prostatic adenocarcinoma. We will discuss successively the biological and dosimetric specificity of brachytherapy for this particular cancer. Afterwards, we will review the main phase II and III studies, the therapeutic indications in the daily practice from the evidence based medicine as well as the techniques of external beam radiation therapy for the same indications. Finally, the principal avenues of development will be discussed.

MeSH Term

Adenocarcinoma
Antineoplastic Agents, Hormonal
Brachytherapy
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Evidence-Based Medicine
Humans
Male
Prostatic Neoplasms
Radiation Injuries
Radiation Tolerance
Radiometry
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
Radiotherapy, Image-Guided
Risk Assessment
Ultrasonography

Chemicals

Antineoplastic Agents, Hormonal

Word Cloud

Created with Highcharts 10.0.0willdoseratebrachytherapyradiationindicationsarticleaimspresentinginteresthightreatmentprostaticadenocarcinomadiscusssuccessivelybiologicaldosimetricspecificityparticularcancerAfterwardsreviewmainphaseIIIIIstudiestherapeuticdailypracticeevidencebasedmedicinewelltechniquesexternalbeamtherapyFinallyprincipalavenuesdevelopmentdiscussed[Highprostatebrachytherapy]

Similar Articles

Cited By